(856) 485-9814

Dual Diagnosis & Co-Occurring Disorders Treatment · Integrated Residential Care

Dual Diagnosis Treatment in South Jersey & Greater Philadelphia

Integrated Residential Care for Co-Occurring Mental Health and Substance Use Disorders in Merchantville, NJ

For patients and families in South Jersey, Cherry Hill, Camden County, or Greater Philadelphia searching for dual diagnosis treatment, integrated rehab for co-occurring mental health and addiction, or residential care that treats depression, anxiety, PTSD, or bipolar disorder alongside substance use — Maplewood Treatment Solutions provides evidence-based integrated dual diagnosis treatment. One clinical team. One treatment plan. Both conditions, addressed together. Patients are treated with dignity, respect, and individualized clinical care.

Joint Commission Accredited  |  LegitScript Certified  |  NJ Licensed Treatment Center

✓ Medically reviewed byEdward Pearson, MD · Medical Director·Last reviewed: May 14, 2026

Accreditations, Credentials & Clinical Capabilities

Why Patients Trust Maplewood for Integrated Dual Diagnosis Treatment

Accredited by Joint Commission Chamber of Commerce of Southern New Jersey Member LegitScript Certified
Joint Commission Accredited
Gold Seal of Approval — the national benchmark for behavioral health treatment quality, safety, and clinical performance.
NJ Department of Health Licensed
Licensed by the New Jersey Department of Health as a residential substance use disorder treatment facility with co-occurring mental health treatment authority.
LegitScript Certified
Independent third-party verification of legitimate, legally compliant addiction treatment operations.
Medical Director on Staff
Dr. Edward Pearson, MD — physician oversight of medical, psychiatric, and integrated dual diagnosis care across the residential program.
Clinical Director on Staff
Marcus Joseph, LCADC, LAMFT, CCS — clinical oversight, individual therapy, and family work integrated into residential care.
Nursing Coverage
Clinical nursing support throughout the residential stay for medical monitoring, medication administration, and patient care.
Dual Diagnosis Specialization
Integrated treatment for substance use alongside co-occurring depression, anxiety, PTSD, bipolar disorder, ADHD, and sleep disorders — treated as connected conditions, not separate problems.
Trauma-Informed Clinical Model
Trauma-informed care framework shapes every clinical interaction, from intake conversation to group facilitation — built on SAMHSA’s six guiding principles.

The Short Version

What Integrated Dual Diagnosis Treatment Means at Maplewood — In Plain English

Dual diagnosis treatment at Maplewood is residential clinical care for people who have both a mental health condition and a substance use disorder — addressed together, by the same clinical team, on a single treatment plan. Integrated care is widely considered the standard of care for many people with co-occurring conditions. Our program addresses the most common combinations we see: depression and substance use, anxiety and substance use, PTSD and substance use, bipolar disorder and substance use, ADHD and substance use, and trauma-driven substance use. Patients arrive medically cleared from acute withdrawal at a detox facility. Our program provides psychiatric medication management, evidence-based therapy, FDA-approved substance use medications when clinically appropriate, trauma-informed care, family work, and outpatient continuity planning before discharge.

Specialized Care Across Dual Diagnosis Presentations

Who We Treat for Co-Occurring Mental Health and Substance Use Disorders

Dual diagnosis does not look the same in every patient. Treatment plans are individualized based on which mental health condition is present, what substance use is involved, trauma history, prior treatment, medical comorbidities, and life circumstances. Maplewood treats patients across the following common presentations:

Depression + Substance Use
Patients with major depressive disorder or persistent depressive disorder alongside alcohol, opioid, or other substance use. Often described in plain terms as “drinking because of depression” or “using to feel something other than empty.”
Anxiety + Substance Use
Patients with generalized anxiety, panic disorder, or social anxiety using alcohol, benzodiazepines, opioids, or cannabis to manage symptoms — often with rebound anxiety that worsens the original condition.
PTSD + Substance Use
Patients with post-traumatic stress disorder, complex PTSD, or unresolved trauma alongside substance use — treated within our trauma-informed clinical framework.
Bipolar Disorder + Substance Use
Patients with bipolar I or II alongside substance use, where mood episodes drive use and use destabilizes mood. Mood stabilization and psychiatric medication coordination are central to the clinical plan.
ADHD + Substance Use
Patients with attention-deficit/hyperactivity disorder alongside substance use, often with self-medication patterns involving stimulants, alcohol, or cannabis. Psychiatric evaluation and individualized medication planning are part of intake.
Sleep Disorders + Substance Use
Patients with chronic insomnia or other sleep disorders using alcohol, benzodiazepines, or other sedatives to sleep — with sleep treated as part of the clinical picture, not a downstream symptom.
Trauma History + Substance Use
Patients whose substance use is closely connected to childhood adverse experiences, complex trauma, grief, or other unresolved trauma history — even when formal PTSD criteria are not met.
Prior Treatment for Only One Condition
Patients with previous treatment history that addressed substance use without integrated mental health care — or addressed mental health without integrated addiction treatment — and are now seeking a different clinical model.

A Specific Clinical Framework, Not a Marketing Term

What Dual Diagnosis Actually Is in Clinical Terms

Clinical team meeting with a patient during integrated dual diagnosis assessment in a residential treatment setting

Dual diagnosis — also called co-occurring disorders — is the clinical term for having both a substance use disorder and a mental health condition at the same time. It is not a marketing label, and it is not a soft category. It is a specific clinical framework recognized by the Substance Abuse and Mental Health Services Administration (SAMHSA), the American Psychiatric Association, and the American Society of Addiction Medicine as a distinct clinical presentation that requires a distinct treatment model.

The clinical reality: when both conditions are present, they typically interact. The mental health condition can drive substance use. The substance use can intensify mental health symptoms. Treating only one and leaving the other unaddressed often produces fragile outcomes — which is why integrated care, where both conditions are treated together by the same clinical team, is the model that has emerged as the standard of care over the past several decades.

Learn more about related care we provide:

Co-Occurring Disorders Program → Trauma-Informed Care →

National Data on Co-Occurring Disorders

How Common Are Co-Occurring Mental Health and Substance Use Disorders?

“Roughly half of adults with a substance use disorder also have a co-occurring mental health condition.”

— Substance Abuse and Mental Health Services Administration (SAMHSA)

According to data summarized by SAMHSA and the National Institute of Mental Health, co-occurring disorders affect millions of U.S. adults each year. In actual clinical treatment settings — the people who walk into residential rehab — the rate is typically even higher than the national average, because untreated mental health conditions are one of the strongest clinical drivers of substance use that escalates to the point of needing inpatient care.

Despite the prevalence, only a fraction of people with co-occurring disorders receive treatment that addresses both conditions. Many receive treatment for the substance use alone, treatment for the mental health condition alone, or sequential care that hands the patient between two unconnected clinical teams. The clinical literature increasingly supports integrated treatment — same team, same plan, both conditions — as the model associated with the strongest long-term outcomes.

The Stakes of Treating Only One Condition

Why Integrated Dual Diagnosis Treatment Matters for Long-Term Recovery

When dual diagnosis is present, treating only the substance use is treating only half the clinical picture. The mental health condition that was driving the use — the depression that made the alcohol feel necessary, the anxiety that made the benzodiazepines feel essential, the trauma symptoms that made the opioids feel like the only relief — remains untreated. The pressure that drove substance use to begin with is still operating after discharge.

Integrated dual diagnosis treatment addresses both conditions in the same plan, by the same clinical team, in the same residential setting. Psychiatric medication management stabilizes mood, anxiety, sleep, and attention symptoms. Substance use disorder treatment addresses the behavioral patterns, triggers, and physiology of use. Trauma-informed care shapes how every interaction happens. Discharge planning maintains continuity into outpatient psychiatric care and therapy. Without that integration, post-treatment relapse risk may remain significantly elevated.

A Brief Clinical History of How the Standard of Care Shifted

Why Integrated Dual Diagnosis Treatment Is Considered the Standard of Care

For most of the 20th century, addiction and mental health were treated in completely separate clinical systems. A patient with depression and alcohol use disorder might be sent to two different facilities, by two different teams, on two different schedules. The result, repeatedly documented in the clinical literature, was patients falling through the gap between systems — and outcomes that did not hold.

Six clinical realities that shaped the shift toward integrated dual diagnosis care:

  • ●The handoff problem. Sequential care — treating the substance use first, then handing the patient to a mental health provider — often broke down in the gap. The mental health condition that was supposed to be addressed “after stabilization” frequently was not addressed at all.
  • ●Parallel-care fragmentation. Even when both conditions were being treated at the same time, the two clinical teams often never communicated. Medication decisions, therapy modalities, and discharge plans were uncoordinated — sometimes contradictory.
  • ●The self-medication framework. Clinical research increasingly documented that for many patients, substance use functions in part as self-medication for underlying psychiatric symptoms. Treating the substance use without addressing what it was managing rarely produced stable outcomes.
  • ●The trauma layer. The growing clinical understanding of trauma’s role in addiction — particularly through the ACE study and trauma-informed care research — made clear that trauma-aware integrated care was structurally different from substance-use-only treatment.
  • ●Outcomes data. Studies of integrated dual diagnosis treatment versus sequential or parallel models consistently showed integrated care associated with stronger engagement, retention, and longer-term outcomes for many populations with co-occurring conditions.
  • ●Institutional position statements. SAMHSA, the American Psychiatric Association, and the American Society of Addiction Medicine have all formally endorsed integrated treatment for co-occurring disorders as the preferred clinical model — with specific clinical guidelines describing how it should be structured.

Maplewood’s residential clinical program is built on this integrated model. One team. One plan. Both conditions. Addressed together from intake through discharge.

From the Clinical Team

“A pattern we see often: a patient comes in after their second or third treatment episode and says, ‘Every program treated the drinking. None of them ever asked about the anxiety.’ That sentence is the clinical fingerprint of an unaddressed co-occurring condition. The patient was doing the work that was given to them. It just was not the complete clinical work that was needed. Integrated dual diagnosis treatment is built specifically to close that gap.”

— Marcus Joseph, LCADC, LAMFT, CCS · Clinical Director, Maplewood Treatment Solutions

Evidence-Based, Integrated, Trauma-Informed

How Maplewood Treats Dual Diagnosis at Our Merchantville, NJ Program

Our clinical approach to co-occurring disorders, from intake through discharge:

  • ●Comprehensive medical and psychiatric intake. Our medical team reviews substance use history, mental health symptoms, psychiatric history, medication history, trauma history, medical comorbidities, and family circumstances on day one. This intake shapes the individualized integrated plan from the start.
  • ●Psychiatric diagnostic clarification. Some patients arrive with a confirmed mental health diagnosis. Others arrive with strong suspicion that something more is going on. Our psychiatric team confirms, refines, or identifies the clinical picture as substance use clears.
  • ●Integrated psychiatric medication management. Antidepressants, mood stabilizers, anti-anxiety medications, ADHD treatments, and sleep medications are managed by our psychiatric team in coordination with substance use treatment — adjusted in real time as the clinical picture evolves.
  • ●FDA-approved substance use medications when clinically appropriate. For patients with opioid use disorder or alcohol use disorder, FDA-approved medications (Suboxone, Vivitrol, naltrexone, acamprosate, disulfiram) are evaluated and prescribed when clinically indicated.
  • ●Evidence-based therapy modalities. CBT, DBT, motivational interviewing, relapse prevention, and trauma-focused approaches are used because they have evidence behind them for both substance use and the most common co-occurring mental health conditions.
  • ●Trauma-informed clinical environment. Many patients with dual diagnosis have trauma histories. Our trauma-informed care framework shapes every interaction, from intake conversation to group facilitation.
  • ●Family work when clinically appropriate. Dual diagnosis often affects the family system. Our family therapy work, led by a Licensed Associate Marriage and Family Therapist, is integrated into residential care.
  • ●Continuity of care into both outpatient streams. Before discharge, your case manager connects you to an outpatient psychiatric prescriber, an outpatient therapist familiar with dual diagnosis populations, and a step-down level of care. Continuity is associated with improved long-term recovery outcomes.

These components are designed to work together as part of an individualized residential treatment plan. That clinical integration is what makes residential dual diagnosis treatment different from any single intervention in isolation.

Clinical Care & Daily Structure at Maplewood

What Patients Receive in Residential Dual Diagnosis Treatment at Maplewood

Medical & Psychiatric Intake
Comprehensive day-one review of substance use history, mental health symptoms, prior treatment, trauma history, medical comorbidities, and family circumstances.
Integrated Treatment Plan
One clinical team. One plan. Both conditions addressed in coordinated, sequenced, and individualized clinical work.
Psychiatric Medication Management
Antidepressants, mood stabilizers, anti-anxiety medications, ADHD treatments, and sleep medications managed by our psychiatric team throughout residential stay.
SUD Medications When Indicated
FDA-approved Medication-Assisted Treatment options for opioid use disorder and alcohol use disorder when clinically appropriate.
Individual & Group Therapy
CBT, DBT, motivational interviewing, relapse prevention, trauma-focused approaches, and process groups delivered by licensed clinical staff.
Discharge & Aftercare Planning
PHP, IOP, outpatient therapy, outpatient psychiatric prescriber, and sober living referrals coordinated before you leave residential.

Ready to Talk Through Next Steps?

Speak With Admissions About Dual Diagnosis Treatment

If you or a loved one is searching for integrated dual diagnosis treatment in South Jersey or Greater Philadelphia, our admissions team can walk you through what the process actually looks like — without a sales script.

  • →How integrated treatment works
  • →Free, confidential insurance verification
  • →Psychiatric medication coordination
  • →Trauma-informed care planning
  • →What level of care may be appropriate
  • →Family involvement options

Confidential · HIPAA-Compliant · No Pressure · No Sales Script

A Common Question From Patients & Families

What Happens on Day One of Residential Dual Diagnosis Treatment?

Patients arrive at Maplewood medically cleared from acute withdrawal at a detox facility. Day one focuses on clinical orientation, medical and psychiatric intake, room and roommate introduction, basic program orientation, and meeting members of the clinical team who will be part of the residential plan. There is no expectation that patients participate in full programming on the first day — the priority is clinical stabilization, comfort, and a clear understanding of what the next phase of care looks like. Within the first 24 to 48 hours, our medical and psychiatric team completes a comprehensive review and builds your individualized treatment plan.

How dual diagnosis treatment plans are developed:

  • ●Biopsychosocial assessment. A structured intake covering the biological (medical history, medications, sleep, nutrition), psychological (mental health symptoms, trauma history, prior treatment), and social (family system, employment, housing, recovery resources) dimensions that shape the clinical picture.
  • ●ASAM 6 dimensions. The American Society of Addiction Medicine’s framework scores acute intoxication/withdrawal, biomedical conditions, emotional/behavioral conditions, readiness to change, relapse potential, and recovery environment — the standard clinical framework for matching patients to appropriate levels of care.
  • ●Psychiatric evaluation. Formal psychiatric assessment for the specific co-occurring condition(s) involved — depression, anxiety, PTSD, bipolar, ADHD, sleep disorders — with medication recommendations when clinically appropriate. This is the diagnostic clarification phase of dual diagnosis treatment.
  • ●Trauma screening. Trauma history is assessed during intake using trauma-informed approaches. For patients with significant trauma, this shapes how therapy, group, and medication planning are sequenced over the residential stay.
  • ●Individualized integrated treatment plan. The clinical team translates the assessment into a specific plan: which psychiatric medications fit, which substance use medications fit, which therapy modalities to prioritize, what trauma-aware sequencing is needed, and what discharge path to start building toward.

For a detailed walk-through of the first 24 hours of residential care — including what to bring, what to expect from staff, and what your loved ones can expect to hear — see our patient and family guide: what happens during the first day of residential treatment.

The Treatment Continuum — Built Into Discharge Planning

What Happens After Residential Dual Diagnosis Treatment?

Residential is the beginning of integrated dual diagnosis care, not the end of it. Continuity of both psychiatric and substance use treatment across the levels below is associated with improved long-term outcomes. Before you leave Maplewood, your case manager builds a discharge plan that connects you to the right next step.

Partial Hospitalization (PHP)
Day-program structure most days of the week. Highest-intensity outpatient level. Appropriate when continued clinical structure is needed but 24-hour residential is no longer required.
Intensive Outpatient (IOP)
Group and individual therapy several times per week. Allows return to work or school while keeping clinical structure in place.
Standard Outpatient (OP)
Weekly therapy and check-ins. Often the long-term level patients step down into and remain in for months to years of recovery support.
Psychiatric Continuity
Before discharge, we connect you to an outpatient psychiatric prescriber to continue medication management. No gap in psychiatric care.
Therapy Continuity
Individual therapy referrals to outpatient clinicians with experience in dual diagnosis populations, ideally trauma-informed where indicated.
Relapse Prevention Planning
Written, individualized relapse-prevention plan covering high-risk situations, coping skills, support contacts, and early warning signs for both conditions.
Outpatient Referrals
Coordinated referrals to PHP, IOP, OP, or psychiatric providers near the patient’s home in South Jersey, Greater Philadelphia, or wherever the patient is returning.
Sober Living Options
For patients who would benefit from a structured living environment after residential, our team helps identify recovery residences that align with the dual diagnosis plan.
Alumni & Ongoing Support
Maplewood maintains a connection with patients after discharge through alumni outreach, recovery community resources, and family support touchpoints.

The right step-down depends on the patient’s clinical picture, home environment, employment, family system, and insurance. Discharge planning at Maplewood is individualized, built into the residential stay — not handed over at the door.

A Question Patients Ask Honestly — And It Deserves an Honest Answer

Can Both Conditions Really Be Treated at the Same Time?

The clinical answer is yes — and the broader clinical evidence increasingly supports doing so. Integrated dual diagnosis treatment is built on the premise that addressing both conditions in parallel, by the same team, on a single plan, is associated with better long-term outcomes than sequential or fragmented care for many people with co-occurring disorders.

For many patients with dual diagnosis, the integrated approach is what makes the rest of recovery possible: the mental health condition stops driving the substance use, the substance use stops destabilizing the mental health condition, and both can be addressed clinically without one being treated as secondary.

Patient engaged in a clinical therapy session as part of integrated dual diagnosis treatment at Maplewood Treatment Solutions in Merchantville, NJ

A few clinical realities worth understanding:

  • ●Diagnostic clarification takes time. Some mental health symptoms become clearer once substance use stops — what looked like one condition may turn out to be another, or the opposite. Our psychiatric team continues evaluating throughout the residential stay rather than locking in a diagnosis on day one.
  • ●Medication adjustments happen in real time. As substance use clears, psychiatric symptoms often shift. Doses may be adjusted, medications may change. The medication plan is treated as a living clinical document, not a one-time prescription.
  • ●Trauma-aware sequencing matters. For patients with significant trauma history, trauma-focused therapy is typically introduced gradually, after stabilization. Trauma work is not avoided — it is sequenced clinically for safety and effectiveness.
  • ●Both conditions get the same clinical weight. In an integrated model, the mental health condition is not treated as a downstream issue to be handled later. It gets the same attention, the same clinical resources, and the same priority as the substance use.
  • ●The result is one plan, not two. The patient does not leave residential with one plan for sobriety and a separate plan for mental health. They leave with one integrated plan that addresses both, and an outpatient pathway that maintains that integration.

If you have been told in the past that you needed to “get sober first” before mental health treatment could begin, that approach is no longer considered the standard of care for most patients with co-occurring disorders. Integrated treatment is what an evidence-based dual diagnosis program is designed to deliver.

For Families Wondering About Dual Diagnosis Care

What Families Most Often Ask About Dual Diagnosis Treatment

Some of the most important calls we take come from spouses, parents, adult children, and siblings — not the patient. If you are trying to figure out whether a loved one’s pattern is dual diagnosis, here’s what we hear most often.

Signs your loved one may need dual diagnosis treatment specifically

Substance use treatment alone may not be enough when the following patterns are present:

  • A previously diagnosed mental health condition (depression, anxiety, PTSD, bipolar, ADHD) that has never been treated alongside substance use
  • Strong suspicion of an undiagnosed mental health condition based on symptoms, behavior, or family history
  • Substance use that started or escalated in clear connection to a traumatic event, loss, or period of mental health crisis
  • Multiple prior treatment episodes for substance use that did not hold
  • Mental health symptoms that get notably worse when substance use stops
  • Self-medication patterns (drinking to sleep, using to manage anxiety, using stimulants to function)

When single-diagnosis treatment may not be enough

If your loved one has been to substance use treatment without mental health care being integrated — or has been to mental health treatment without addiction care being integrated — the relapse cycle may be a sign that the missing half of the clinical picture needs to be addressed. The clinical fix is usually not another round of the same kind of program. It is a different model: integrated dual diagnosis care delivered by one team, in one residential setting, on one coordinated plan.

How families can support someone in integrated treatment

Family involvement is associated with improved engagement and long-term recovery support for many patients. Concretely, that often looks like:

  • Participating in family programming and family therapy sessions during the residential stay
  • Learning about both the mental health condition and the substance use so behavior changes are understood as clinical, not personal
  • Supporting psychiatric medication adherence and outpatient follow-through after discharge
  • Maintaining the family’s own support — through Al-Anon, NAMI, a therapist, or family-specific clinical resources
  • Being patient with the timeline; dual diagnosis recovery is non-linear, and clinical setbacks are part of the picture, not a personal failure

Our family therapy program, led by our Clinical Director (LAMFT), is integrated into residential care for the families who want to be part of the recovery work.

Patterns That May Indicate Co-Occurring Conditions

Signs of Dual Diagnosis — Patterns Patients & Families May Notice

If several of the following patterns are present, integrated dual diagnosis treatment may be the appropriate clinical model:

Using substances to manage anxiety or depression
Mental health symptoms worse after substance use stops
Prior diagnosis of depression, anxiety, PTSD, bipolar, or ADHD
Multiple prior treatment episodes that did not hold
Trauma history that was never assessed in prior treatment
Psychiatric medication started and stopped multiple times
Chronic insomnia that responds only to substances
Mood swings that pre-date substance use
Family history of mental illness alongside substance use
Self-medication patterns (drinking to sleep, using to function)
Intrusive memories, flashbacks, or panic episodes during recovery attempts
Substance use that started in clear connection to a mental health crisis

What South Jersey & Greater Philadelphia Families Search For

Questions People Ask About Dual Diagnosis Treatment

“dual diagnosis treatment near me South Jersey”
“co-occurring disorders rehab NJ”
“depression and addiction treatment Cherry Hill”
“PTSD and substance use rehab Philadelphia”
“anxiety and alcohol treatment NJ”
“integrated dual diagnosis program”
“what is dual diagnosis”
“bipolar and substance use treatment South Jersey”

Common Clinical & Practical Questions

Dual Diagnosis Treatment FAQ — What Patients & Families Most Often Ask

What exactly is dual diagnosis?

Dual diagnosis — also called co-occurring disorders — is the clinical term for having both a substance use disorder and a mental health condition at the same time. Common combinations include depression and alcohol use, anxiety and benzodiazepine or opioid use, PTSD and substance use, bipolar disorder and substance use, and ADHD and substance use. The clinical reality is that when both conditions are present, they typically interact — which is why integrated treatment that addresses both at once is the standard of care.

What is the difference between dual diagnosis and co-occurring disorders?

In current clinical use, the two terms are synonymous — both refer to the simultaneous presence of a mental health disorder and a substance use disorder. “Dual diagnosis” is the older clinical term still widely used in treatment settings. “Co-occurring disorders” is the term federal bodies like SAMHSA prefer in current policy and guidance documents. They describe the same clinical reality.

Why is integrated treatment considered the standard of care?

Sequential and parallel care models have a long clinical history of patients falling through the gap between systems. Integrated treatment — same team, same plan, both conditions — addresses that gap. SAMHSA, the American Psychiatric Association, and the American Society of Addiction Medicine all formally endorse integrated dual diagnosis treatment as the preferred clinical model for co-occurring disorders.

Can anxiety cause addiction?

The clinical relationship is bidirectional. Untreated anxiety can drive substance use — many patients describe using alcohol, benzodiazepines, opioids, or cannabis to manage anxiety symptoms in patterns that escalate over time into a substance use disorder. The substance use can then intensify anxiety, particularly between doses. This pattern of using substances to self-medicate anxiety is one of the most common dual diagnosis presentations we see in patients from Cherry Hill, Marlton, Voorhees, Mount Laurel, and Camden County. Integrated treatment addresses both the anxiety and the substance use as connected clinical problems.

Can PTSD cause substance abuse?

Trauma history and PTSD are strongly associated with substance use disorders in the clinical literature. Patients often describe substance use as a way to suppress intrusive memories, hyperarousal, nightmares, or emotional dysregulation tied to trauma. Treating substance use without addressing the underlying trauma rarely produces stable outcomes — which is why our trauma-informed care framework is integrated into dual diagnosis treatment from intake forward.

Can depression get worse after stopping substances?

It can. When substance use was partially masking depressive symptoms, stopping the substance often reveals the underlying depression more clearly. This is one reason psychiatric evaluation throughout the residential stay matters — the clinical picture often shifts in the first weeks of sobriety. Our psychiatric team monitors mood symptoms continuously and adjusts the treatment plan as the depression becomes more visible clinically. This is not a setback; it is part of why integrated treatment is structured the way it is.

What if I have anxiety and alcohol addiction?

Anxiety and alcohol use disorder is one of the most common dual diagnosis combinations we treat at our Merchantville, NJ residential program. Patients arrive medically cleared from acute alcohol withdrawal and enter integrated care that addresses both conditions on a single plan — including psychiatric evaluation for the anxiety, FDA-approved AUD medications when clinically appropriate (naltrexone, acamprosate, disulfiram), evidence-based therapy (CBT, DBT), and trauma-informed care when indicated. Many of our patients with this combination come from Camden County, Burlington County, and Gloucester County, including Cherry Hill, Marlton, Voorhees, Haddonfield, Collingswood, Deptford, and Washington Township.

Can bipolar disorder and addiction be treated together?

Yes — integrated treatment is associated with better outcomes than treating either condition alone. Bipolar disorder and substance use frequently co-occur, with mood episodes driving use and use destabilizing mood. Our psychiatric team coordinates mood-stabilizer medication management alongside substance use treatment in a single integrated plan. Treating one condition while ignoring the other has a long clinical history of producing relapse cycles in either direction.

What happens if mental health is untreated during rehab?

Substance use treatment without integrated mental health care has a documented clinical pattern of patients leaving with the addiction part of the picture addressed and the mental health condition still unmanaged — which often drives relapse within weeks to months of discharge. This is the single most common reason patients who genuinely committed to treatment relapse anyway. Integrated dual diagnosis treatment is built specifically to address this gap. For a deeper look, see our blog post Why People Relapse After Rehab.

What if my mental health diagnosis is new or unconfirmed?

Many patients arrive at residential care with strong suspicion of a mental health condition but no formal diagnosis — or with a diagnosis that has not been clearly confirmed. Our psychiatric team evaluates during intake and throughout the residential stay. As substance use clears, the clinical picture often becomes more visible. Diagnostic clarification is part of dual diagnosis treatment, not a barrier to it.

Will I be on psychiatric medication forever?

Not necessarily. Psychiatric medication is one tool among several in dual diagnosis treatment. For some conditions and some patients, long-term medication is part of clinical management. For others, medication is short-term or transitional. Medication decisions are individualized based on the specific condition, severity, response to treatment, and patient preferences. Your psychiatric provider discusses the rationale, options, and timeline as part of the treatment plan.

How long is residential dual diagnosis treatment?

Length of stay is individualized based on clinical assessment, the specific co-occurring conditions involved, prior treatment history, insurance authorization, and discharge planning needs. Many patients with dual diagnosis benefit from 30 to 90 days of residential care, followed by step-down to PHP, IOP, or outpatient treatment with continued psychiatric and therapy support.

Does insurance cover dual diagnosis treatment in NJ?

Most major commercial insurance plans cover integrated dual diagnosis treatment in New Jersey as part of residential substance use disorder care. Maplewood Treatment Solutions accepts Aetna, BlueCross BlueShield, Cigna, United Healthcare, AmeriHealth, Independence Blue Cross, Humana, Magellan Health, Beacon Health Options, Optum, and ComPsych. Coverage details, in-network status, and out-of-pocket costs vary by plan, policy, and clinical assessment. We serve patients across South Jersey — Camden County, Burlington County, Gloucester County — and Greater Philadelphia. Verification is free and confidential, often the same day you call. Call (856) 485-9814 or use our online insurance verification form.

How Dual Diagnosis Care Connects to Our Wider Clinical Program

Integration With Maplewood’s Full Continuum of Care

Dual diagnosis treatment at Maplewood is the connective tissue of our residential clinical program. Our patients receive coordinated psychiatric medication management, Medication-Assisted Treatment for opioid or alcohol use disorder, trauma-informed care, and family therapy within a single residential setting. For substance-specific clinical care, see our alcohol rehab and heroin and opioid treatment pages. To learn more about how integrated dual diagnosis treatment works in practice, see our Co-Occurring Disorders Program overview or our blog post Why People Relapse After Rehab — and What Integrated Dual Diagnosis Treatment Is Designed to Address.

Serving South Jersey & the Philadelphia Region

Dual Diagnosis Treatment Near Cherry Hill and Philadelphia

Geographic accessibility matters in concrete ways for patients and families seeking integrated dual diagnosis treatment. Where care happens shapes how families participate, how aftercare gets coordinated, and how realistic the long-term recovery plan is. Maplewood Treatment Solutions is positioned to serve South Jersey, Camden County, Burlington County, Gloucester County, and the Greater Philadelphia region with a residential program designed for the way co-occurring disorders care actually happens here.

Our Merchantville, NJ Location
Maplewood is located at 214 W Maple Ave in Merchantville, NJ — just minutes from Route 38, Route 70, Route 295, and the Ben Franklin Bridge. The residential program is set in a clinical environment built specifically for South Jersey families.
Serving Across South Jersey
Patients come to Maplewood from Cherry Hill, Marlton, Voorhees, Mount Laurel, Pennsauken, Haddonfield, Camden, Collingswood, Sicklerville, Mount Holly, and surrounding communities throughout Camden and Burlington counties.
Accessibility From Philadelphia Suburbs
Maplewood is readily accessible from Greater Philadelphia — Center City, South Philly, Northeast Philly, and the Pennsylvania suburbs — via the Ben Franklin Bridge and Route 30. Many patients and families come from the Philadelphia metro area.
Continuity Into Local Outpatient
Our discharge planning team coordinates with PHP, IOP, outpatient psychiatric prescribers, and dual-diagnosis-experienced therapists across Camden County, Burlington County, and Philadelphia.
Family Participation Made Practical
Because Maplewood is centrally located, families across South Jersey and Greater Philadelphia can participate in family therapy programming without an overnight trip.

Communities We Serve in South Jersey & Greater Philadelphia

Dual Diagnosis Treatment Serving Communities Across South Jersey

Patients and families from across the region come to Maplewood for residential dual diagnosis treatment, including:

Merchantville, NJ
Cherry Hill, NJ
Marlton, NJ
Voorhees, NJ
Mount Laurel, NJ
Pennsauken, NJ
Haddonfield, NJ
Camden, NJ
Greater Philadelphia

Find Maplewood Treatment Solutions

Visit Us in Merchantville, NJ

Maplewood Treatment Solutions is located at 214 W Maple Ave in Merchantville, NJ. Convenient access from Cherry Hill, Camden, Pennsauken, and Greater Philadelphia.

📍 View Our Location
214 W Maple Ave, Merchantville, NJ 08109

214 W Maple Ave, Merchantville, NJ 08109  |  (856) 485-9814

Real Stories From Real People

What South Jersey & Greater Philadelphia Clients Say About Maplewood

★★★★★ 4.8 Based on 30 Google Reviews
★★★★★

"My experience at Maplewood was life changing. The staff treated me like family and gave me the structure I needed to actually start recovery."

M
Maura F.
Google Review
★★★★★

"Maplewood gave me a real shot at recovery when I had been turned away from other places. The clinical team actually listens."

G
G.
Google Review
★★★★★

"As a family member of someone who came through Maplewood, I cannot say enough about how compassionate and professional the team is."

N
Norbert L.
Google Review
★★★★★

"Maplewood saw me as a person, not a number. Their work around dual diagnosis was exactly what I needed."

M
Meredith M.
Google Review

Evidence-Based Care, Backed by National Standards

Clinical Standards & Editorial Review at Our Merchantville, NJ Treatment Center

Content on this page is informed by evidence-based co-occurring disorders treatment principles and reviewed against recognized clinical standards from the following authoritative bodies:

SAMHSA — Co-Occurring Disorders
Substance Abuse and Mental Health Services Administration resources on integrated dual diagnosis treatment.
APA — Addiction & Substance Use
American Psychiatric Association practice guidelines on substance use disorder and co-occurring conditions.
ASAM — National Practice Guideline
American Society of Addiction Medicine guideline on standards of care for substance use disorders, including co-occurring conditions.
NIMH — Substance Use & Mental Health
National Institute of Mental Health research on co-occurring substance use and mental disorders.
NIDA — Comorbidity Research
National Institute on Drug Abuse research on the relationship between substance use disorders and mental health conditions.
CDC — Behavioral Health Surveillance
Centers for Disease Control data on substance use, mental health, and behavioral health outcomes.

Clinical Review & Editorial Standards

This content was clinically reviewed for accuracy regarding:

  • dual diagnosis and co-occurring disorders treatment
  • evidence-based integrated residential addiction treatment
  • psychiatric medication management in residential settings
  • trauma-informed care and trauma-substance use overlap
  • continuity of care between residential and outpatient psychiatric services

Medically & Clinically Reviewed By:

E
Medical Director, Maplewood Treatment Solutions
License: Doctor of Medicine (MD) · View Dr. Pearson’s clinical bio →
M
Clinical Director, Maplewood Treatment Solutions
Licenses: Licensed Clinical Alcohol & Drug Counselor (LCADC) · Licensed Associate Marriage & Family Therapist (LAMFT) · Certified Clinical Supervisor (CCS) · View Marcus’s clinical bio →

Last clinically reviewed: May 14, 2026

Next scheduled review: November 2026 · Review cycle: every 6 months

Maplewood Treatment Solutions content is informed by evidence-based resources including SAMHSA, APA, ASAM, NIMH, NIDA, and CDC guidance where appropriate. Learn more about our clinical team and credentials: Meet the Staff →

This page is for informational purposes only and does not constitute medical advice. Dual diagnosis treatment decisions are individualized based on clinical evaluation. Maplewood Treatment Solutions is Joint Commission accredited and LegitScript certified.

Authoritative Sources Informing This Page

Clinical References & Sources

Content on this page is informed by the following clinical bodies, federal agencies, and research institutions:

  1. Substance Abuse and Mental Health Services Administration (SAMHSA). Co-Occurring Disorders and Other Health Conditions. samhsa.gov/medications-substance-use-disorders
  2. American Society of Addiction Medicine (ASAM). The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions. asam.org/asam-criteria
  3. American Society of Addiction Medicine (ASAM). National Practice Guideline for the Treatment of Opioid Use Disorder. asam.org/quality-care/clinical-guidelines
  4. National Institute of Mental Health (NIMH). Substance Use and Co-Occurring Mental Disorders. nimh.nih.gov/health/topics/substance-use-and-mental-health
  5. American Psychiatric Association (APA). Addiction and Substance Use Disorders. psychiatry.org/patients-families/addiction-substance-use-disorders
  6. National Institute on Drug Abuse (NIDA). Comorbidity: Substance Use Disorders and Other Mental Illnesses. nida.nih.gov/research-topics/comorbidity
  7. Centers for Disease Control and Prevention (CDC). Adverse Childhood Experiences (ACE) Study. cdc.gov/violenceprevention/aces
  8. National Institutes of Health (NIH). Trauma and Stress-Related Disorders Research. nimh.nih.gov/health/topics/post-traumatic-stress-disorder-ptsd
  9. SAMHSA. TIP 42: Substance Use Disorder Treatment for People With Co-Occurring Disorders. store.samhsa.gov/product/tip-42
  10. SAMHSA. Trauma-Informed Care in Behavioral Health Services (TIP 57). store.samhsa.gov/product/tip-57

Continue Reading on Dual Diagnosis & Recovery

Related Reading From Maplewood

Pillar Article

What Is Dual Diagnosis? A Complete Guide to Co-Occurring Disorders
The foundational clinical overview of dual diagnosis.

Clinical Deep-Dive

Why People Relapse After Rehab — and What Integrated Dual Diagnosis Treatment Addresses
The clinical pattern behind relapse and why integrated care matters.

Companion Read

Why Integrated Dual Diagnosis Treatment Matters for Mental Health and Addiction Recovery
How the integrated treatment model is structured in practice.

Patient Guide

What to Expect on Day One of Residential Treatment in South Jersey
A walk-through of the first 24 hours at Maplewood.

Service Page

Trauma-Informed Care at Maplewood
How trauma-aware clinical work is integrated into residential care.

Treatment Program

Co-Occurring Disorders Program
The integrated dual diagnosis treatment program in detail.

Clinical Modality

Cognitive Behavioral Therapy (CBT)
How CBT supports dual diagnosis and addiction recovery.

Clinical Modality

Dialectical Behavior Therapy (DBT)
DBT for emotional regulation, distress tolerance, and dual diagnosis.

Take the Next Step

If You’re Searching for Integrated Dual Diagnosis Treatment — Start Here

No pressure. No sales script. Just a confidential conversation with a clinical admissions team that can help you figure out the right next step — whether that’s Maplewood or somewhere else.

“dual diagnosis treatment near me NJ”
“co-occurring disorders rehab Cherry Hill”
“integrated mental health and addiction rehab Philadelphia”

Joint Commission Accredited · LegitScript Certified · NJ Licensed Treatment Center

Maplewood Treatment Solutions — 214 W Maple Ave, Merchantville, NJ 08109 — (856) 485-9814